Driven by aggressive state policies and a national supercomputing network, Chinese labs are rapidly embedding AI into daily ...
Mass General Brigham has started offering a blood test that estimates a person’s inherited risk for eight different ...
A decade ago, many startups viewed patents as optional or defensive filings. Today, patents are increasingly tied to fundraising, licensing discussions, collaborations, and investor confidence. In ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice ...
When 68-year-old retiree Ellen Costello received an email asking if she wanted to participate in a medical study about artificial intelligence and breast cancer, she hesitated at first. Did she really ...
SINGAPORE – Safeguards and upcoming new laws in Singapore will ensure that genetic information from patients will not be available to their medical insurance company, the Ministry of Health (MOH) has ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere ...
For as little as $2,500, you can choose your future baby. Should you? Hosted by Ross Douthat Produced by Katherine SullivanAndrea BetanzosSophia Alvarez Boyd and Victoria Chamberlin Mr. Douthat is an ...
SINGAPORE - Eligible Singapore residents will be able to screen for a genetic condition that causes high cholesterol levels at a subsidised rate, as part of a nationwide programme launching on June 30 ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
A U.S. startup company is reportedly offering wealthy couples the chance to screen their embryos for IQ and other favorable genetic traits, which has raised ethical concerns. Heliospect Genomics is ...
Lamotrigine, a drug commonly used to treat epilepsy and certain mood disorders, has been shown to be an excellent treatment option for a rare genetic neuromuscular disease known as non-dystrophic ...